Osteoarthritis (OA) is a chronic degenerative disease characterized predominantly by cartilage degradation, wherein extracellular matrix (ECM) proteins play pivotal roles in its pathogenesis. Proteins such as Asporin (ASPN), Cartilage Intermediate Layer Protein (CILP), Chondroadherin (CHAD), Fibulin-3 (EFEMP1), Pannexin 3 (PANX3), and C-terminal cross-linking telopeptide of type II collagen (CTX-II) exhibit aberrant expression patterns in OA cartilage, influencing chondrocyte metabolism, signaling pathways, and matrix homeostasis. This review provides a comprehensive overview of the altered expression and molecular functions of these ECM-related proteins in OA, emphasizing their interactions with key signaling cascades including TGF-β, Wnt, and BMP pathways. Incorporating recent advances from single-cell sequencing and gene editing technologies, we explore how these proteins serve as potential biomarkers and therapeutic targets. Furthermore, the review delves into the impact of post-translational modifications of ECM proteins on OA pathology, aiming to elucidate mechanisms that underpin precise diagnosis and targeted treatment strategies. By synthesizing current findings, this article seeks to advance understanding of ECM protein-mediated regulatory networks in OA and foster the development of innovative interventions for cartilage preservation and repair.

Autism spectrum disorder (ASD) and attention-deficit/hyperactivity disorder (ADHD) are prevalent neurodevelopmental disorders in childhood and adolescence in which neuroimmune dysregulation and altered microglial function have been increasingly implicated, albeit with substantially different levels of human versus preclinical evidence. Preclinical (in vitro and rodent) studies indicate that contracting skeletal muscle secretes bioactive exercise-induced factors (exerkines)—including irisin, cathepsin B, lactate, and extracellular vesicles—that can directly cross or indirectly signal across the blood–brain barrier, modulate microglial inflammatory states, and support synaptic plasticity. However, whether this complete peripheral-to-central cascade operates to normalize synaptic pruning in children and adolescents with ASD or ADHD remains unconfirmed. In this review, we propose the developmental muscle–microglia axis as a hypothesis-generating conceptual framework and specifically focus on its intersection with pubertal maturation. We critically synthesize in vitro, animal, and human evidence on how key exerkines and multi-pathway brain-derived neurotrophic factor (BDNF) regulation may interact with surging sex hormones during the pubertal transition to influence microglial activity and neuroepigenetic states. Furthermore, we frame modality-specific exercise parameters (FITT-VP model) and multimodal wearable/biomarker closed-loop monitoring as candidate hypotheses and conceptual proposals for future clinical trials in youth with ASD and ADHD, while highlighting methodological limitations, safety considerations, and translational gaps.